Intra-Cellular Therapies

Intra-Cellular Therapies

NJ - Bedminster
Biotechnology
WebsiteLinkedInCareers Page

Focus: Small molecules for neurology

Intra-Cellular Therapies is a life sciences company focused on Small molecules for neurology.

Neurology
Open Jobs
5

Products & Portfolio (1)

CAPLYTA
lumateperone
Peak
ORAL · CAPSULE
adults, for the treatment of depressive episodes associated with bipolar depression (as monotherapy or as adjunctive therapy with lithium or valproate), and as adjunctive therapy with antidepressants for the treatment of MDD is unknown. However, the mechanism of action of lumateperone for these uses could be mediated through a combination of antagonist activity at central serotonin 5-HT 2A receptors, and partial agonist activity at central dopamine D 2 receptors.
schizophreniadepression
2019
0

Open Jobs (5)

Internal Control Sr. Analyst (Accountant)

Bogotá Distrito Capital, Colombia (Hybrid)
Finance
2w ago

障がい者採用【ジョンソン・エンド・ジョンソン日本法人グループ】

Chiyoda, Japan (Hybrid)
Non-Standard
2w ago

District Account Manager- Biosurgery Specialist

Gurgaon, India
MedTech Sales
2w ago

EAMA manager

Beijing / China (Hybrid)
Market Access
2w ago

Senior Local Trial Manager

High Wycombe, United Kingdom (Hybrid)
R&D Operations
2w ago
Interview Prep Quick Facts
Portfolio: 1 approved product
Top TAs: Neurology, Psychiatry
Open Roles: 5 active jobs
Portfolio Health
Peak1 (100%)
1 total products
Therapeutic Area Focus
Neurology
1 marketed
Psychiatry
1 marketed
Marketed
Pipeline